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doi:10.1Objective: We developed a validated 50-point recipient risk index predicting short-term mortality after ortho-
topic heart transplant (OHT). This study examined the relationship between institutional volume and recipient
risk on post-OHT mortality.
Methods:We used United Network for Organ Sharing (UNOS) data to identify primary OHT recipients between
January 2000 and April 2010. Centers were stratified by mean annual volume. Preoperative Index for Mortality
Prediction After Cardiac Transplantation risk scores were calculated for each patient with our validated 50-point
system. Primary outcomes were 30-day and 1-year survivals. Multivariable logistic regression analysis included
interaction terms to examine effect modification of risk and volume on mortality.
Results: In all, 18,226 patients underwent transplant at 141 centers: 1173 (6.4%) recipients at low-volume cen-
ters (<7 procedures/y), 5353 (29.4%) at medium-volume centers (7-15 procedures/y), and 11,700 (64.2%) at
high-volume centers (>15 procedures/y). Low center volume was associated with worse 1-year mortality
(odds ratio, 1.58; 95% confidence interval, 1.30-1.92; P< .001). For 1-year survival, there was significant
positive interaction between center volume and recipient risk score (odds ratio, 1.04; 95% confidence interval,
1.01-1.07; P¼ .02), indicating effect of risk on mortality at low-volume centers greater than from either variable
analyzed individually. Among high-risk recipients (score 10), 1-year survival was improved at high-volume
centers (high, 79%; medium, 75%; low, 64%).
Conclusions: In analysis of UNOS data with our validated recipient risk index, institutional volume acted as an
effect modifier on association between risk and mortality. High-risk patients had higher mortality at low-volume
centers; differences dissipated among lower-risk recipients. These data support a mandate for high-risk trans-
plants at higher-volume centers. (J Thorac Cardiovasc Surg 2012;143:157-67)Supplemental material is available online.e Division of Cardiac Surgery,a Department of Surgery, the Division of Car-
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XMore than 30 years have elapsed since the early observation
that outcomes for a broad array of surgical procedures im-
provewith increasing hospital center volume.1 Many subse-
quent studies have documented this relationship for
a spectrum of surgical procedures.2-10 Specifically, in the
field of solid organ transplantation, volume–outcome
associations have been demonstrated in population-based
studies for kidney, liver, lung, and heart transplants.11-15
In the absence of prospective data, these previous studies
could only identify associations. These associations likely
represent the different systems or processes of care among
centers with different levels of procedural volume, which
are difficult to measure objectively.
It is possible that certain centers may only have the insti-
tutional experience and support framework to treat patients
within a given risk profile. Recipient risk and center volume
have been examined in orthotopic heart transplant (OHT)
recipients; however, the assignment of recipient risk was
not fully characterized.14 We recently developed a novel,
quantitative recipient risk index for mortality prediction af-
ter cardiac transplant, the Index forMortality Prediction Af-
ter Cardiac Transplantation (IMPACT), from the data in the
United Network for Organ Sharing (UNOS) registry.16 The
effect of center volume was not included in the original IM-
PACT study, because the aim of that initial study was tordiovascular Surgery c Volume 143, Number 1 157
Abbreviations and Acronyms
CI ¼ confidence interval
IMPACT ¼ Index for Mortality Prediction After
Cardiac Transplantation
OHT ¼ orthotopic heart transplant
OR ¼ odds ratio
UNOS ¼ United Network for Organ Sharing
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Xdefine a recipient risk index that was broadly applicable on
the basis of only recipient characteristics. In this study, we
incorporated the IMPACT risk index to test the hypothesis
that the effect of recipient risk on short-term mortality after
OHT varies by different levels of center volume. This inter-
action, or effect modification, has not been previously stud-
ied for OHT.With a validated risk index, these findings may
begin to explain the previously observed outcome differ-
ences associated with center volume.MATERIALS AND METHODS
Data Source
UNOS provided Standard Transplant Analysis and Research files with
donor-specific and follow-up data from October 1, 1987, to December
31, 2010. The registry consists of a prospectively collected database of
unique demographic, donor, operative, and postoperative information for
all thoracic transplant recipients in the United States. No patient or center
identifiers were included, and this study was granted exemption status by
the institutional review board.
Study Design
This was a retrospective review involving all primary, adult (18 years)
OHT recipients from January 2000 to April 2010, to ensure adequate time
for follow-up. All patients who received simultaneous liver transplants
(n ¼ 69), and those with total artificial hearts (n ¼ 71) were excluded.
All patients included in the analysis were assigned the appropriate IM-
PACT risk score.13 The IMPACT risk score is a quantitative risk index de-
rived from and cross-validated with UNOS data, and it has been shown to
be highly predictive of 1-year mortality for adult patients undergoing first-
time OHT.16 The risk index incorporates 12 recipient-specific preoperative
variables (age, sex, ethnicity, diagnosis, creatinine clearance, preoperative
dialysis, serum bilirubin, preoperative infection, need for mechanical ven-
tilation, intra-aortic balloon pump, temporary circulatory support, and ven-
tricular assist device) to assign relative points out of a possible maximum of
50 (Table E1). No patients were missing the data necessary to compose
their respective scores.
Center Volume
Center code was provided as a random encrypted alphanumeric
6-character code unique to each individual center. Center and patient level
data were deidentified in this data set. The variable of average annual center
volume for each center was derived from existing data. Accordingly, each
patient outcome was linked with the corresponding hospital volume calcu-
lation. Years in which a center was clearly not performing OHT procedures
were subtracted for purposes of average annual volume determination. An-
nual center volume was then ranked in thirds, with each center counting as
an individual observation, and categorized as low (7 OHT procedures/y),
medium (>7 to15 OHT procedures/y), or high (>15 OHT procedures/y).158 The Journal of Thoracic and Cardiovascular SurgCategorization in this fashion prevented skewing the cut points upward
because of a greater overall number of patients undergoing OHT at
higher-volume centers. For ease of interpreting regression coefficients,
center volume was reported as a categoric variable in regression analysis;
however, we also examined center volume as a continuous variable to aid in
identifying inflection points regarding risk of 1-year mortality.
Analysis
The primary outcomes of interest were all-cause 30-day and 1-year
mortalities. Additional postoperative complications examined were
drug-treated rejection in the first year after transplant, postoperative renal re-
placement therapy, and need for cardiac reoperation. Multivariable logistic
regression analysis incorporated recipient risk (IMPACT) score, allograft is-
chemic time, donor age, and annual center volume (low, medium, or high).
Allograft ischemic time and center volume were examined as both continu-
ous and categoric variables with cutoffs with the Akaike information crite-
rion used to identify models with highest explanatory power in a nested
model approach. According to the Akaike information criterion, the multi-
variable regressionmodels using these 2 variableswith cut points as categoric
variables increased the explanatory power of the models. Separate regres-
sions were performed for 30-daymortality and 1-yearmortality. The Pearson
c2 goodness-of-fit test and area under the receiver operating characteristic
curves were used to confirm the explanatory power of the regression models.
To test for an effect modification of center volume on recipient risk and
short-term mortality, an interaction term was constructed. This interaction
term consisted of the product of recipient risk score and the inverse of an-
nual center volume. In this way, risk estimates of the individual compo-
nents of the interaction term would be unidirectional, facilitating
interpretation of the coefficients. When added to the multivariable regres-
sion models, this interaction term allowed the odds of early mortality to
vary by level of center volume.
One-year survival was modeled according to the Kaplan-Meier method,
with censoring for patients unavailable for follow-up or for administrative
purposes (alive at the end of the study). A subgroup survival analysis was
performed among patients in the highest quartile of risk (IMPACT score
>10). Means are displayed with SDs, medians with interquartile ranges,
and odds ratios (ORs) with 95% confidence intervals (CIs). Biostatistical
analysis was performed with STATA software (version 11 SE; StataCorp
LP, College Station, Tex).
RESULTS
Cohort Statistics
There were 18,226 OHT recipients who satisfied inclu-
sion criteria, and these transplants were performed at a total
of 141 unique centers. The mean agewas 52 12 years, and
4311 (23.7%) were women. Recipient ethnic distribution
was as follows: 73.1% white (n ¼ 13,328), 16.4% African
American (n ¼ 2,988), 7.2% Hispanic (n ¼ 1311), and
3.3% other (n¼ 599). Donor ethnic distribution was as fol-
lows: 69.0% white (n ¼ 12,573), 13.2% African American
(n ¼ 2405), 15.3% Hispanic (n ¼ 2793), and 2.5% other
(n ¼ 455). During the study period, 4892 patients died (in-
cidence 6.6 deaths/100 person-years). The Kaplan-Meier
cumulative incidence of 1-year mortality was 13.6%
(n¼ 2223). Median follow-up was 45 months (interquartile
range, 15-75 months).
Center Volume
Mean annual institutional volume ranged from 0.2 OHT
procedures/y to 76 OHT procedures/y, with a median of 10ery c January 2012
TABLE 1. Patient characteristics and postoperative outcomes stratified by center volume
Variable
Volume
P value*Low (N ¼ 1173) Medium (N ¼ 5353) High (N ¼ 11,700)
Demographics
IMPACT score (mean  SD) 6.3  4.0 6.2  3.7 6.2  3.8 .8
Age (y, mean  SD) 48.9  13.9y 51.7  11.9y 52.5  12.1 <.01
Female (no.) 262 (22.4%) 1318 (24.6%) 2731 (23.3%) .1
White (no.) 839 (71.5%)y 3792 (70.8%)y 8697 (74.3%) <.01
African American (no.) 226 (19.3%)y 952 (17.8%)y 1810 (15.5%) <.001
Diagnosis (no.) <.01
Idiopathic 452 (38.5%) 2288 (42.7%) 4988 (42.6%)
Ischemic 535 (45.6%) 2508 (46.9%)y 5165 (44.2%)
Congenital 89 (7.6%)y 95 (1.8%)y 285 (2.4%)
Other 97 (8.3%) 462 (8.6%) 1262 (10.8%)
Acuity
Hypertension (no.) 373 (39.7%) 1593 (44.0%)y 3200 (39.0%) <.01
Diabetes mellitus (no.) 220 (18.9%)y 1301 (24.5%) 2677 (23.2%) <.01
Creatinine clearancez (mL/min, mean  SD) 68.8  27.1y 67.3  27.1y 65.5  25.5 <.01
Serum bilirubin (mg/mL, mean  SD) 1.4  3.1y 1.2  2.2 1.3  2.3 .02
Preoperative mechanical ventilation (no.) 34 (2.9%) 172 (3.2%)y 277 (2.4%) <.01
Ischemic time (h, mean  SD) 3.0  1.1y 3.1  1.0y 3.3  1.0 <.01
Temporary circulatory supportx (no.) 26 (2.2%)y 62 (1.2%) 165 (1.4%) .1
Ventricular assist device
Early generationk (no.) 188 (16.0%) 891 (16.6%)y 1724 (14.7%) <.01
Late generation{ (no.) 5 (0.4%) 34 (0.6%) 45 (0.4%) .08
HeartMate II (no.) 24 (2.1%)z 307 (5.7%)y 571 (4.9%) <.01
Intra-aortic balloon pump (no.) 43 (3.7%)y 267 (5.0%) 656 (5.6%) <.01
Postoperative outcomes
Need for cardiac reoperation (no.) 120 (13.0%) 409 (11.7%) 881 (11.6%) .4
Stroke (no.) 26 (2.2%) 140 (2.6%) 250 (2.2%) .2
New-onset dialysis (no.) 113 (9.9%)y 423 (8.1%)y 799 (7.2%) <.01
Treated rejection in first year (no.) 355 (40.3%)y 1457 (34.4%)y 2598 (28.8%) <.01
IMPACT, Index for Mortality Prediction After Cardiac Transplantation. *P value based on analysis of variance (continuous variables) or c2 test (categoric variables). yPost hoc
pairwise comparison P<.05 (reference high-volume centers) by Tukey-Kramer method for continuous variables or univariate logistic regression for categoric variables. zBased
on Cockcroft-Gault calculation.5 xIncludes extracorporeal membrane oxygenation or extracorporeal ventricular assist devices: Abiomed BVS5000 (Abiomed, Inc, Danvers,
Mass), Bio-Medicus (Medtronic, Inc, Minneapolis, Minn), TandemHeart (Cardiac Assist, Inc, Pittsburgh, Pa), and Levitronix/Centrimag (Levitronix, Waltham, Mass). kEarly
generation includes paracorporeal and intracorporeal pulsatile ventricular assist devices: Abiomed AB5000, HeartMate I (Thoratec Corporation, Pleasanton, Calif), XE and XVE,
ThortecIVAD (Thoratec), Toyobo (Toyobo Co, Ltd, Osaka, Japan), Novacor (World Heart Inc, Oakland, Calif), Medos (Medos Medizintechnik AG, Stolberg, Germany), and
LionHeart (Arrow International Inc, Reading Pa). {Later-generation continuous ventricular assist devices including Jarvik (Jarvik Heart, Inc, New York, NY), MicroMed De-
bakey (MicroMed Cardiovascular, Inc, Houston, Texas), and VentrAssist (Ventracor, Sydney, Australia), excluding HeartMate II.
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XOHT procedures/y. Primary stratification revealed that 173
patients (6.4%) underwent transplant at centers with low
volume (7 OHT procedures/y, n ¼ 47), 5353 patients
(29.4%) at centers with medium volumes (>7 to 15
OHT procedures/y, n ¼ 47), and 11,700 (64.2%) at centers
with high volumes (>15 OHT procedures/y; n ¼ 47).
Seventy-four centers (52.4%) performed more than 10
OHT procedures/y, and 28 centers (19.8%) performed
more than 20 OHT procedures/y.
IMPACT Score Generation
After assigning all patients their respective risk score in-
dex values, the average score for the entire cohort was 6.24
 3.77. A histogram and test for skewness revealed that the
pattern of scores followed a normal distribution, with
values ranging from 0 to 33. When divided into quartiles,The Journal of Thoracic and Cathe breakdown of scores was as follows: quartile 1, 0 to
less than 3 (n ¼ 4528; 24.8%); quartile 2, 3 to less than
6 (n ¼ 3908; 21.4%); quartile 3, 6 to less than 9
(n ¼ 5760; 31.6%); and quartile 4, at least 9 (n ¼ 4030;
22.1%). There were 2129 patients (11.6%) with a risk
score greater than 10 and only 92 (0.5%) with a risk score
greater than 20.
Baseline Characteristics
Baseline characteristics were compared among the 3 cen-
ter volume groups (Table 1). For post hoc comparisons the
high-volume group served as the reference. Although there
were several differences in baseline characteristics, patients
were evenly matched among the 3 groups when examining
overall recipient risk as assessed by the IMPACT risk score
(P¼ .8). Patients at high-volume centers tended to be whiterdiovascular Surgery c Volume 143, Number 1 159
FIGURE 1. A, Bar graph depicting actual 30-day mortality by center vol-
ume (low, medium, and high) according to increasing risk strata. P values
are nonsignificant except where explicitly noted on the plot region. B, Bar
graph depicting actual 1-year mortality by center volume (low, medium,
and high) according to increasing risk strata.P values are nonsignificant ex-
cept where explicitly noted on the plot region.OHT,Orthotopic heart trans-
plant.
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Xand older. The presence of diabetes mellitus, renal dysfunc-
tion, intra-aortic balloon pump, and prolonged ischemic
time were also more common among recipients at high-
volume centers. Patients at low-volume centers tended to
have congenital cardiac disease, tended to have higher se-
rum bilirubin levels, and were more likely to be African
American. At medium-volume centers, there were more
patients with ischemic cardiomyopathy, history of hyper-
tension, need for mechanical ventilation, and use of early-
generation ventricular assist devices.Mortality and Risk-Adjusted Regression Analysis
At30days, the unadjusted observedmortalitieswere 4.6%
(high-volume centers), 5.6% (medium-volume centers), and
9.3% (low-volume centers). Observed 1-yearmortalities, un-
adjusted for recipient risk, were 11.6% (high-volume cen-
ters), 13.5% (medium-volume) and 18.1% (low-volume
centers). Differences in observed mortality by center volume
weremore pronouncedwhen examined across increasing risk
strata (Figure 1), with significant differences at 30 days and 1
year. In the adjusted multivariable logistic regression160 The Journal of Thoracic and Cardiovascular Surganalysis, each 1-point increase in recipient risk score corre-
sponded to a 14% increase in the odds of 1-year mortality
(OR, 1.14; 95%CI, 1.13-1.15; P<.001; Table 2). Increasing
donor age (OR, 1.01; 95% CI, 1.00-1.02; P<.001) and pro-
longed allograft ischemic time (OR, 1.75; 95% CI, 1.42-
2.15; P<.001) also increased the odds of 1-year mortality.
For the 1-year mortality logistic regression model, the area
under the receiver operating characteristic curve was 0.67,
and the Pearsonc2 statisticwas 5180 (P¼ .25), indicating ac-
ceptable model fit.
When allowing the effect of recipient risk on 1-year
mortality to vary by center volume, there was a positive
and significant test of interaction (OR, 1.04; 95% CI,
1.01-1.07; P< .001). This interaction signifies that high-
volume centers minimized the effect of recipient risk,
whereas low-volume centers amplified the odds of
1-year mortality associated with higher recipient risk.
This effect modification is depicted graphically in
Figure 2. As recipient risk scores increased, the difference
in observed 1-year mortality for each tier of center volume
became more pronounced, with observed mortality ex-
ceeding predicted mortality for low-volume and
medium-volume centers. Conversely, the risk of death
for high-volume centers was lower than would be pre-
dicted from the model, implying protection for high-risk
patients at higher-volume centers. It is important to note
that there were many low-volume centers that also
achieved low 1-year mortality results, as shown in
Figure 3. Because low-volume centers had a higher prev-
alence of congenital heart disease, the entire analysis was
performed again without patients with congenital heart
disease to ensure that this variable was not confounding
the results. The magnitude and significance levels of the
ORs for center volume, IMPACT risk score, and the inter-
action effect remained similar (test of interaction OR,1.06;
95% CI, 1.02-1.10; P ¼ .004).
Incorporating 4 quartiles of recipient risk according to the
IMPACT risk score, relative risk of 1-year mortality is plot-
ted against center volume as a continuous variable in
Figure 4. As center volume increases from 0 to 10 OHT pro-
cedures/y, there is a steep decline in risk of 1-year mortality
for all 4 tiers of recipient risk, although the decline is least
pronounced in the lowest-risk recipients. In the 2 lower quar-
tiles of recipient risk, the relative risk of 1-year mortality
crosses a threshold of 1 at a center volume of approximately
10 OHT procedures/y. In contrast, for patients in the upper 2
quartiles according to IMPACT risk score, the inflection
point for relative risk of 1-year mortality occurs at a center
volume of approximately 35 OHT procedures/y, with an ob-
served plateau beyond 35 to 40 OHT procedures/y. Consis-
tent with this relative ratio plot, when center volume was
examined as a continuous variable in the regression, increas-
ing center volume was associated with lower odds of 1-year
mortality (OR, 0.99; 95% CI, 0.98-0.99; P<.01).ery c January 2012
TABLE 2. Odds ratio estimates for 30-day and 1-year mortalities
Variable
30-d 1 y
OR 95% CI P value OR 95% CI P value
Without volume–risk interaction effect
IMPACT score 1.15 1.14–1.17 <.001 1.14 1.13–1.15 <.001
Center volume
High Reference — — Reference — —
Medium 1.28 1.10–1.49 .001 1.22 1.10–1.35 <.001
Low 2.25 1.80–2.82 <.001 1.76 1.50–2.09 <.001
Allograft ischemic time
<2 h Reference — — Reference — —
2 h to<4 h 1.20 0.93–1.54 .2 1.06 0.90–1.25 .4
4 h to<6 h 1.91 1.46–2.49 <.001 1.58 1.33–1.89 <.001
>6 h 2.54 1.88–3.43 <.001 1.75 1.42–2.15 <.001
Donor age 1.01 1.01–1.02 <.001 1.01 1.01–1.02 <.001
With volume–risk interaction effect
IMPACT score 1.15 1.13–1.16 <.001 1.13 1.12–1.15 <.001
Center volume
High Reference — — Reference — —
Medium 1.29 1.12–1.49 .001 1.20 1.09–1.33 <.001
Low 1.86 1.46–2.38 <.001 1.58 1.30–1.92 <.001
Center volume–risk interaction effect 1.03 1.01–1.06 .04 1.04 1.01–1.07 .02
Allograft ischemic time
<2 h Reference — — Reference — —
2 h to<4 h 1.20 0.93–1.55 .2 1.06 0.91–1.25 .4
4 h to<6 h 1.92 1.46–2.51 <.001 1.59 1.33–1.89 <.001
>6 h 2.51 1.86–3.39 <.001 1.75 1.42–2.15 <.001
Donor age 1.01 1.01–1.02 <.001 1.01 1.01–1.02 <.001
IMPACT, Index for Mortality Predication After Cardiac Transplantation; OR, odds ratio; CI, confidence interval.
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When comparing survival by center volumewith the Cox-
Mantel log-rank test, there was improved 1-year survival at
high-volume centers (P < .001; Figure 5, A). Post hocFIGURE 2. Best-fit Lowess smoothed line for observed 1-year mortality by leve
mortality according to Index for Mortality Prediction After Cardiac Transplanta
tality is in the shaded area. OHT, Orthotopic heart transplant.
The Journal of Thoracic and Cacomparisons revealed a significant difference between
high-volume and medium-volume centers for the cohort
overall (P ¼ .04). High-risk patients only (IMPACT score
10) were examined in a subgroup analysis, and thel of center volume (low, medium, and high) plotted against predicted 1-year
tion (IMPACT) score. The 95% confidence interval (CI) for predicted mor-
rdiovascular Surgery c Volume 143, Number 1 161
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FIGURE 3. Scatter plot of center-level 1-year mortality according to 3
tiers of center volume.
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Xsignificant survival differences persisted (P<.001; Figure 5,
B). In this high-risk subgroup, post hoc testing revealed
a trend toward a difference in 1-year survival between
high-volume and medium-volume centers (P ¼ .056).Postoperative Complications
Commonly encountered postoperative complications, ac-
cording to center volume groups, are shown at the bottom of
Table 1. Rates of cardiac reoperation and postoperativeFIGURE 4. Relative risk of 1-year mortality plotted against center vol-
ume as a continuous variable on the abscissa. Stratification was performed
according to 4 quartiles of recipient risk according to the Index for Mortal-
ity Prediction After Cardiac Transplantation (IMPACT) risk index. Relative
risk crosses 1 for the lower 2 quartiles at an annual center volume of ap-
proximately 10 orthotopic heart transplant (OHT) procedures/y, whereas
for the 2 higher quartiles of recipient risk, the risk of 1-year mortality
crosses 1 at an annual center volume of approximately 35 to 40 orthotopic
heart transplant procedures/y.
162 The Journal of Thoracic and Cardiovascular Surgstroke were similar among the 3 groups. New-onset dialy-
sis, however, was more common at low-volume and
medium-volume centers (low, 9.9%; medium, 8.1%;
high, 7.2%; P< .01). In addition, drug-treated rejection
in the first year after transplant was more prevalent among
low-volume and medium-volume centers (low, 40.3%; me-
dium, 34.4%; high, 28.8%; P<.01).
DISCUSSION
We used UNOS data to evaluate the effect of recipient
risk (as assessed by the IMPACT risk score) on short-term
post-OHT mortality across different levels of transplant
center volume. Since 2000, in the United States most
OHT procedures have been performed at high-volume cen-
ters (64%), in stark contrast with low-volume centers (6%).
Accounting for recipient risk, we observed improved 1-year
survivals among higher-volume centers, improvements that
were most pronounced in the highest quartile of recipient
risk. After incorporating tests of interaction in multivariable
analysis, institutional volume modified the effect between
recipient risk and mortality.
As recipient risk increased, decreasing center volume
amplified the risk of early mortality after OHT. This ampli-
fication of risk was most pronounced in the range of recip-
ient scores from 10 to 20. Beyond a risk score of 20, the
best-fit lines for observed mortality migrated back within
the bounds of the 95% CI estimates for predicted mortality,
likely related to outliers and small numbers of patients in
extreme risk categories (Figure 2). In fact, fewer than 1%
of all OHT procedures in this study were performed on
OHT recipients with scores greater than 20, and it is there-
fore difficult to draw meaningful conclusions for this subset
of patients. Nonetheless, it is clear that high-risk patients
survived with greater frequency than predicted by the IM-
PACT model at higher-volume centers; conversely, they
died with greater frequency than predicted at low-volume
centers.
There were several differences in baseline characteristics
among the 3 groups of center volume, with high-volume
centers tending to OHT recipients with advanced age,
more frequent diabetes mellitus, worse renal function, and
more frequent use of intra-aortic balloon pumps. Although
centers varied in these individual characteristics, it is impor-
tant to emphasize that overall risk as assessed by the
composite risk index was equivalent in the 3 groups.
High-volume centers tended to transplant organs with
slightly longer ischemic times, and this factor was adjusted
for in the multivariable analysis. Low-volume centers were
more likely to perform OHT on African American recipi-
ents, patients with congenital heart disease, and patients
with higher bilirubin levels. Because of the size of the data-
base, several of these statistically significant differences
may not have clinical relevance. Congenital heart disease
can be a risk factor for adverse outcomes after OHT,ery c January 2012
FIGURE 5. A, Kaplan-Meier cumulative 1-year survival of recipients in the cohort overall, stratified by center volume. B, Kaplan-Meier cumulative 1-year
survival of high-risk recipients (risk score>10), stratified by center volume. OHT, Orthotopic heart transplant.
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Xhowever, and the prevalence of congenital heart disease was
3-fold higher at low-volume centers. We therefore per-
formed a sensitivity analysis that excluded patients with
congenital heart disease from the entire analysis. The re-
sults remained the same as with congenital heart disease in-
cluded, suggesting that this variable was not confounding
the results.
Analysis of postoperative complications may partially
explain the observed survival differences. Postoperative
stroke and cardiac reoperation rates were equivalent in the
3 center volume groups. Drug-treated rejection in the first
year after OHT was more common in low-volume and
medium-volume centers than in high-volume centers, how-
ever, with an absolute difference between low-volume and
high-volume centers of 12.5%. Although it is difficult to
determine from the UNOS database, these differences in
drug-treated rejection rates may have been due to inade-
quately delivered immunosuppression, with the conse-
quence of more rejection-related deaths. Furthermore,
postoperative dialysis was more common in low-volume
and medium-volume centers. The independent effect of
postoperative renal dysfunction on mortality in cardiacThe Journal of Thoracic and Casurgical patients is well known.17 The UNOS variables
for these postoperative complications are not reliably coded
in the UNOS database, and thus caution is warranted in gen-
erating strong conclusions from these data fields.
There are numerous causes of death reported in the
UNOS database, with the most common being multisystem
organ failure, primary graft failure or cardiac arrest, bacte-
rial septicemia, and respiratory failure. Nearly 20% of this
cohort was missing cause of death information, however,
thus preventing reliable use of this variable. Nevertheless,
we speculate that the higher rates of dialysis and rejection
likely contributed to the differences in observed 30-day
and 1-year mortalities. In addition, there were significant
differences in 30-day mortality among the different tertiles
of center volume, and this suggests that early perioperative
deaths may in part account for the observed differences in
1-year mortality.
Processes of Care
The principal aim of this study was to achieve a better un-
derstanding of the way in which heart transplant centers in-
teract with OHT recipients across the spectrum of recipientrdiovascular Surgery c Volume 143, Number 1 163
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sarily be used to impugn low-volume centers, because there
are certain low-volume centers that achieve excellent out-
comes across the spectrum of recipient risk. Although indi-
vidual surgeon and provider experience may plausibly
account for these results, this issue is clearly quite complex,
and these data likely underscore variability in processes of
care that may be inherently different across different tiers
of center volume. Recent studies have demonstrated that
dedicated intensive care unit staff, development of patient
safety measures, and integration of critical care pathways
may significantly affect outcomes.8,18,19 The results of
this study should foster further inquiry into systems-based
processes of care that may account for these differences
in early survival.
Although the specific drivers of the volume effect remain
undefined, these data strongly suggest that high-risk OHT
recipients are best treated at higher-volume centers. Before
advocating such a position, however, it is important to con-
sider risks associated with such referral patterns. For exam-
ple, having a high-risk patient travel a greater distance to
undergo OHT at a high-volume center may affect post-
OHT compliance, clinic visits, and routine surveillance,
not to mention the obvious risks incurred from physical
transport of a critically ill patient. Furthermore, from a soci-
etal standpoint, transport costs for both recipients and or-
gans may nullify any potential benefits of regionalization.
Further studies are necessary to examine the specific pro-
cesses of care that impart improved outcomes at higher-
volume centers. Ideally, such studies could elucidate the
most important factors present at higher-volume centers,
and attempts could be made to incorporate them into low-
volume centers. Ongoing monitoring of outcomes and ac-
cess to OHT is also paramount to determine whether this
center effect persists and to ensure that patients are not de-
nied OHT because of an inability to access a higher-volume
center.
With these caveats, however, these data begin to shed
light on why higher-volume centers attain superior results.
We now know that it is specifically because they succeed
with high-risk patients. These are the patients for whom
low-volume centers tend not to achieve equivalent results.
As a result, we support a paradigm shift toward performing
OHT on high-risk patients at higher-volume centers
exclusively.
Previous Work
Although the relationship between hospital volume and
outcomes for surgical procedures was initially described
in the general surgical population, these associations have
been applied to cardiac surgical patients.1,20,21 Previous
studies have identified this relationship specifically in the
context of cardiac transplant as well.12,14,15 Although one
cannot prove causation in a retrospective study, these164 The Journal of Thoracic and Cardiovascular Surgstudies were performed with a nationwide data set.
Hosenpud and colleagues15 conducted the first large regis-
try study with UNOS data in OHT during the years 1987
through 1991, and perioperative care has evolved since
that time. They reported a 33% increase in the risk of
1-year mortality among centers performing fewer than 9
OHT procedures/y. Our group has examined the effect of
center volume on post-OHT mortality in a more contempo-
rary cohort (1999-2006) and found that centers performing
fewer than 01 OHT procedures/y had a 35% increase in the
hazard of 1-year mortality.12 Although recipient variables
were incorporated into a multivariable analysis, that study
was limited in its ability to discriminate the effect of recip-
ient risk and center volume on short-term mortality. More
recently, Russo and colleagues14 investigated recipient
risk and center volume in the context of post-OHTmortality
with UNOS data.14 In addition to corroborating these previ-
ous observations, we believe that our current analysis ex-
pands on these earlier studies in several important ways.
Our current study not only corroborates previous findings
but also expands our understanding of this issue. Specifi-
cally, there has previously been no standardized recipient
risk index for predicting short-term mortality in cardiac
transplant. The study by Russo and colleagues14 incorpo-
rated recipient risk, but that study did not derive a composite
risk score in a test group and validate the findings in a sepa-
rate cohort. Without a composite index, it is difficult to
show generalizability from analysis to analysis. Standardi-
zation of risk is important as we attempt to analyze which
factors lead to improved outcomes for high-risk patients
at higher-volume centers. The 12 variables contributing to
the 50-point IMPACT risk score (Table E1) represent those
most significantly affecting 1-year mortality for first-time
OHT recipients. Furthermore, because of the rigorous sta-
tistical methodologies used to derive the risk score, we be-
lieve that our findings are robust and accurately reflect how
an individual OHT recipient’s risk profile affects the risk of
early mortality at different levels of center volume. Addi-
tionally, although interaction effects have been examined
in liver transplants, this is the first study of cardiac trans-
plants to incorporate interaction terms to assess the varying
effects of recipient risk across different strata of center
volume.22
Furthermore, the assignment of center volume for OHT
has varied in the literature. Russo and colleagues14 defined
high-volume as greater than 47 OHT procedures/y, whereas
the Center for Medicare and Medicaid Services currently
stipulates that centers perform at least 10 OHT proce-
dures/y to maintain certification.23 To assign center volume
tertiles, we considered each center (with its respective aver-
age annual volume) as a single observation, rather than con-
sidering each patient as an individual observation. We
believe that deriving cut points as was done in this study
more accurately reflects a center’s annual OHT experience.ery c January 2012
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in the upward direction because of a greater overall number
of patients undergoing OHT at higher-volume centers. In
our analysis, only 6 centers performed more than 47 OHT
procedures/y, which is too few to be performing all the
high-risk OHT procedures in the United States.
We also treated center volume as a continuous variable. A
visual inspection of relative risk for 1-year mortality sug-
gests that the optimal cut point for low-risk OHT recipients
may be a center volume around 10 OHT procedures/y.
Higher-volume centers performing approximately 35
OHT procedures/y may be best suited to handle the
highest-risk recipients. There are only 9 centers that average
at least 35 OHT procedures/y, however, and although these
data support regionalization of high-risk recipients, 9 cen-
ters may be too few to accommodate all high-risk OHT re-
cipients in the United States. Improved means for
identifying lower-volume centers that achieve excellent
outcomes for high-risk recipients will ensure continued ac-
cess to OHT for the most critically ill patients awaiting car-
diac transplants.
Limitations
Because of the retrospective nature of this study design,
there are certain important limitations. Large national clin-
ical registry studies inherently assume accurate coding of
data. It is impossible to determine coding errors, although
we have assumed that errors of this nature are likely to be
distributed randomly throughout the data set. If this is not
the case, these potential errors may have introduced bias
in our results. An added limitation of this study is the inabil-
ity to make strong conclusions about outcomes at centers
with very low volumes. Even though the UNOS registry
represents a large sample size, centers that perform on aver-
age fewer than 1 OHT procedure/y will have variable out-
comes. In the absence of more low-volume centers to
examine, it is difficult to ascertain whether high mortalities
at low-volume centers represent clear trends or natural var-
iability. Additionally, despite the large patient cohort, the
event rate of 1-year mortality was low among low-risk re-
cipients. Thus this study may have been insufficiently pow-
ered to detect a true survival difference according to center
volume among low-risk recipients.
These findings may not fully account for the interaction
between donor characteristics and recipient risk. We incor-
porated donor age and allograft ischemic time, because
these variables were significantly associated with postoper-
ative mortality on univariate analysis. When combined in
our risk-adjusted multivariable model, the test of interaction
between recipient risk and center volume remained signifi-
cant, suggesting an effect related to center volume indepen-
dent of these donor characteristics. In light of the limited
donor information in the UNOS registry, there may be do-
nor selection factors affecting mortality that vary by centerThe Journal of Thoracic and Caor organ procurement organization, which we have not been
able to consider.
Furthermore, the UNOS database includes limited infor-
mation regarding immunosuppression management, type of
rejection, processes of care, and postoperative complica-
tions. The strength of the UNOS data set is derived from
its relatively complete mortality information. The focus of
this study was therefore on 1-year mortality, with reporting
of various postoperative complications to supplement the
mortality findings. Additionally, retrospective studies can-
not control for unrecognized differences in recipient charac-
teristics. We attempted to account for these potential
differences by incorporating a validated recipient risk in-
dex; however, there may be other variables not accounted
for in our risk index that affect short-term mortality. In de-
veloping scoring systems, validation is a vital feature. In our
original score determinations, we used cross-validation by
deriving the score from a random subset and using the re-
mainder of the sample for validation. This methodology is
unlikely to have biased the validation; however, we ac-
knowledge that our recipient index will benefit from exter-
nal validation in an independent sample.CONCLUSIONS
In an analysis with UNOS data and our novel recipient
risk index, institutional volume acted as an effect modifier
on the association between risk and mortality. High-risk pa-
tients had higher mortality when undergoing OHT at low-
volume centers and lower mortality when undergoing
OHTat higher-volume centers. These differences dissipated
among lower-risk recipients. These data support performing
OHT on high-risk recipients at higher-volume centers.References
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Dr R. Duane Davis (Durham, NC). First, I congratulate you on
an excellent presentation. This is not a shocking finding, in a team
sport like heart transplant, that better outcomes are associated with
higher volumes. I want to focus a little bit more on how you de-
fined what was a large-volume versus a small-volume center.
There was a recent report in the Journal that used essentially the
same UNOS data set that you did. They divided it into quartiles;
in fact, the low volume was approximately 15 and less, and then
marched it up, with the high-volume centers approximately 34
and over. For each of the groups, there was a reduction in the actual
mortality risk. You have added recipient risk, as quantified by your
IMPACT score, to the analysis. High-risk recipients would seem to
do better in centers that are doing higher volumes of procedures.
Did your analysis actually look at where the volume threshold ef-
fect was? Did it continue to decline as the volumes increased? If
you look at the International Society for Heart and Lung Trans-
plantation registry, which puts out the slide every year associating
recipient mortality with center volume, the place where it plateaus
is approximately 35 to 40. I would assume that that would be sim-
ilar in this analysis, but you have tended to focus more on just the
very small versus moderate sized transplant programs.166 The Journal of Thoracic and Cardiovascular SurgDrArnaoutakis. Thank you, Dr Davis, for your kind comments
and important points and questions. With respect to our stratifica-
tion methods, we counted each center as a single observation when
we made our stratifications. We have done our center volume anal-
yses in this fashion in the past, and we believe that it is actually
very important to do it in this fashion. When we divide into tertiles
according to defining average volume in this fashion, there is
roughly a third, or approximately 47 centers, that are above 15
heart transplants per year. When each individual patient is counted
as a single observation, that significantly skews the cut points in
the upward direction. If we were then to define centers according
to those cut points, we would actually limit significantly the num-
ber of centers defined as high volume for the purposes of this study.
So that was why we defined them as such.
In our analysis, we did perform both continuous and categoric,
or dichotomous, cut points for center volume. Because we incor-
porated interaction terms, it becomes increasingly complicated
and difficult to explain simply the effect modification when ex-
amining the interaction among multiple continuous variables.
With regard to your point about the International Society for
Heart and Lung Transplantation registry, however, we did exam-
ine that in a continuous fashion, with spline terms as well as
graphically inspecting Lowes S curves, and it looks to us, espe-
cially for the high-risk recipients derived from UNOS data, which
obviously varies somewhat from the international registry, that
there does seem to be a plateau that occurs between 20 to 30 pro-
cedures per year, which still limits the number of centers al-
though not as much so as when we make cut points above 45,
where then we are only talking about a handful of centers, which
may limit access to care for some patients who are not near these
centers.
DrDavis.The next component of this is that we shouldn’t really
be in the business of trying to shut down programs. It should be in
the idea of how do we improve the quality of all the programs. So
how can we essentially raise the boat? And are there things, and
this is something that you are not going to get out of the UNOS
data set but you can make some assumptions, that are necessary
to be able to do this well? And what can we learn from this type
of data set analysis to say, okay, if you are going to be in the busi-
ness of heart transplant, these are the critical items that you need to
be doing if you are going to be really successful? Again, my con-
gratulations on an excellent presentation.
Dr Arnaoutakis. Thank you again. Your point is absolutely
right and well taken. The study intention and these findings are
not meant to impugn centers of any volume whatsoever. If you
look closely, there are several centers in the low-volume category
that achieve excellent outcomes. And so you are getting at a very
important point, that these findings don’t prove any causation but
show associations. What we need to pursue from here on is to iden-
tify the processes of care that we believe are intimately involved
with these findings. Oneway to do this is to go back to institutional
series, where we have access to variables that are not included in
the UNOS database, which although it has many variables does
not encompass all variables. For example, we have looked in our
institutional series at the distance that patients live from the trans-
plant center and have found an association with greater rates of re-
jection. So there may be some follow-up study that can be
performed at individual centers both in the high-volume end ofery c January 2012
Arnaoutakis et al Cardiothoracic Transplantationthe spectrum and in the low-volume end of the spectrum to identify
these processes of care.
It is difficult with the UNOS database to glean any information
regarding independent surgeon experience and surgeon volume,
which may play some role. As well, perioperative care may vary
across the spectrum of different centers with different volumes,
and we believe that this is also intimately involved with these find-
ings. And so some of the pathways and structures that are set up at
various intensive care units may shed more light on these
differences.
We do believe that these findings begin to shed light on the out-
come differences that we have observed, in that the differences
seem to be dictated in large part by outcomes of recipients who
are at the highest end of the risk spectrum.
Dr Craig R. Smith (New York, NY). Very briefly, did you con-
sider the possibility that a low-volume center that had been in busi-
ness for a long timemight be okay, which youmight see by looking
at total historical transplant volume or total number of survivors?
Dr Arnaoutakis. We didn’t specifically look at that. We did
look over time, and it is difficult to tell whether a center has
gone from 1 to 0 transplants per year if that center remainsThe Journal of Thoracic and Caopen.We looked at the patterns, and wemade assumptions accord-
ing to whether they had closed temporarily and then reopened. We
did incorporate time into our models, but not with the specific
question that you asked. That is an important point, however, for
understanding factors that may play into low-volume centers
that achieve excellent outcomes. That is something that we are go-
ing to look into further.
Dr Giovanni Battista Luciani (Verona, Italy). I enjoyed your
presentation. On one of the first slides, in the lower center volumes
there was a higher prevalence of congenital heart disease as an in-
dication for surgery. I was intrigued by that, because it has been
recognized that this is an increased risk factor for mortality early
and late after transplant. Did you try running your analysis exclud-
ing that diagnosis, and would it come out the same? Thank you.
Dr Arnaoutakis. Thank you for pointing that out. We were in-
trigued by that as well. We didn’t expect to see such a magnitude of
difference. Congenital heart disease is accounted for in our risk
score, and so we actually did not perform the analysis excluding
those patients, because we considered that it was already adjusted
for. So I don’t believe that that would be driving any of these find-
ings, but it is an important thing that we could examine.rdiovascular Surgery c Volume 143, Number 1 167
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TABLE E1. Description of Index for Mortality Predication After
Cardiac Transplantation (IMPACT) risk score and allocation of
points by variable
Covariates
Points
assigned
Age>60 y 3
Bilirubin (serum, mg/dL)
0–0.99 0
1–1.99 1
2–3.99 3
4 4
Creatinine clearance (mL/min)
>50 0
30–49 2
<30 5
Dialysis between listing and transplant 4
Female sex 3
Heart failure etiology
Idiopathic 0
Ischemic 2
Congenital 5
Other 1
Infection 3
Intra-aortic balloon pump 3
Mechanical ventilation before transplant 5
Ethnicity
White 0
African American 3
Hispanic 0
Other 0
Temporary circulatory support (ECMO/extracorporeal VAD) 7
Older-generation pulsatile VAD 3
New-generation continuous VAD (excluding HeartMate II) 5
HeartMate II 0
Total points possible 50
ECMO, Extracorporeal membrane oxygenation; VAD, ventricular assist device.
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